726 related articles for article (PubMed ID: 27084094)
1. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders.
Stefano GB; Challenger S; Kream RM
Eur J Nutr; 2016 Dec; 55(8):2339-2345. PubMed ID: 27084094
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products.
Remor AP; de Matos FJ; Ghisoni K; da Silva TL; Eidt G; Búrigo M; de Bem AF; Silveira PC; de León A; Sanchez MC; Hohl A; Glaser V; Gonçalves CA; Quincozes-Santos A; Borba Rosa R; Latini A
Biochim Biophys Acta; 2011 Nov; 1812(11):1460-71. PubMed ID: 21767639
[TBL] [Abstract][Full Text] [Related]
3. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
4. Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway.
Lv X; Lv GH; Dai GY; Sun HM; Xu HQ
Chin J Nat Med; 2016 Nov; 14(11):844-855. PubMed ID: 27914528
[TBL] [Abstract][Full Text] [Related]
5. The detrimental effects of acute hyperglycemia on myocardial glucose uptake.
Joseph D; Kimar C; Symington B; Milne R; Essop MF
Life Sci; 2014 Jun; 105(1-2):31-42. PubMed ID: 24747137
[TBL] [Abstract][Full Text] [Related]
6. Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes.
He M; Siow RC; Sugden D; Gao L; Cheng X; Mann GE
Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):277-85. PubMed ID: 20227863
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
Rolo AP; Palmeira CM
Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species].
Nishikawa T; Araki E
Rinsho Byori; 2008 Aug; 56(8):712-9. PubMed ID: 18800628
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia and the pathobiology of diabetic complications.
Aronson D
Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
[TBL] [Abstract][Full Text] [Related]
10. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential.
Faria A; Persaud SJ
Pharmacol Ther; 2017 Apr; 172():50-62. PubMed ID: 27916650
[TBL] [Abstract][Full Text] [Related]
11. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
Nishikawa T; Edelstein D; Du XL; Yamagishi S; Matsumura T; Kaneda Y; Yorek MA; Beebe D; Oates PJ; Hammes HP; Giardino I; Brownlee M
Nature; 2000 Apr; 404(6779):787-90. PubMed ID: 10783895
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
Hu XF; Wang L; Xiang G; Lei W; Feng YF
Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
[TBL] [Abstract][Full Text] [Related]
13. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose.
Kim KM; Kim YS; Jung DH; Lee J; Kim JS
Exp Cell Res; 2012 Jan; 318(2):152-9. PubMed ID: 22036650
[TBL] [Abstract][Full Text] [Related]
14. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.
Yamagishi SI; Nakamura N; Matsui T
J Diabetes; 2017 Feb; 9(2):141-148. PubMed ID: 27556881
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end-products and the progress of diabetic vascular complications.
Jakus V; Rietbrock N
Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
[TBL] [Abstract][Full Text] [Related]
16. Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway.
Wu Q; Zhong ZM; Zhu SY; Liao CR; Pan Y; Zeng JH; Zheng S; Ding RT; Lin QS; Ye Q; Ye WB; Li W; Chen JT
Apoptosis; 2016 Jan; 21(1):36-50. PubMed ID: 26520447
[TBL] [Abstract][Full Text] [Related]
17. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.
Coughlan MT; Thorburn DR; Penfold SA; Laskowski A; Harcourt BE; Sourris KC; Tan AL; Fukami K; Thallas-Bonke V; Nawroth PP; Brownlee M; Bierhaus A; Cooper ME; Forbes JM
J Am Soc Nephrol; 2009 Apr; 20(4):742-52. PubMed ID: 19158353
[TBL] [Abstract][Full Text] [Related]
18. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.
Basta G; Lazzerini G; Del Turco S; Ratto GM; Schmidt AM; De Caterina R
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1401-7. PubMed ID: 15845907
[TBL] [Abstract][Full Text] [Related]
19. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
Lalla E; Lamster IB; Schmidt AM
Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
[TBL] [Abstract][Full Text] [Related]
20. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
